Magnussen, L.V.; Helskov Jørgensen, L.; Glintborg, D.; Andersen, M.S.
Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study. Biomedicines 2023, 11, 3184.
https://doi.org/10.3390/biomedicines11123184
AMA Style
Magnussen LV, Helskov Jørgensen L, Glintborg D, Andersen MS.
Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study. Biomedicines. 2023; 11(12):3184.
https://doi.org/10.3390/biomedicines11123184
Chicago/Turabian Style
Magnussen, Line Velling, Louise Helskov Jørgensen, Dorte Glintborg, and Marianne Skovsager Andersen.
2023. "Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study" Biomedicines 11, no. 12: 3184.
https://doi.org/10.3390/biomedicines11123184
APA Style
Magnussen, L. V., Helskov Jørgensen, L., Glintborg, D., & Andersen, M. S.
(2023). Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study. Biomedicines, 11(12), 3184.
https://doi.org/10.3390/biomedicines11123184